- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01419301
Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)
Mindfulness Based Stress Reduction in MS
This study focuses on stress, cognition, mood and fatigue and its effect on medication compliance. Medication compliance is measured by the weight of discarded needles. The investigators will be administering neuropsychological testing at baseline and the final visit. The subjects will complete self-report assessments during their 8 weeks in the study.
Group A will have additional weekly phone support for meditation, while Group B will have meditation training only.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
New York
-
Stony Brook, New York, Spojené státy, 11786-8121
- Stony Brook University
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Patients with either definite MS according to the revised McDonald criteria (Polman 2005) or patients with CIS (defined as an initial MS relapse with objective documentation and 2 or more lesions within the CNS of which at least one must involve the brain)
- Patients on GA therapy for at least 6 months
- Age 18 - 70
Exclusion Criteria:
- Unwilling to comply with study procedures
- Use of other DMT in conjunction with GA
- Unable to provide informed consent.
- Current (past 30 days) substance abuse
- Newly initiated (past 30 days) psychiatry treatment
- Enrolled in another program of meditation in the past six months.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Electronic measure of needle disposals (MEMS TrackCaps)
Časové okno: Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.
|
During the six-week MSBR program, medication adherence will be monitored with a widely used electronic measure of needle disposals (MEMS TrackCaps) This method has been demonstrated to be more accurate in MS than data obtained from either self-report or interview.
At one month intervals the patient will bring the needle container to the Study Coordinator.
All patients who attend at least introduction session and one telephone session will be included in the analysis.
|
Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Perceived Stress Scale-10
Časové okno: Baseline, 1 X between weeks 3-7, Week 8
|
A 10-item scale of global perceived stress, where each item is rated from 1 to 5 according to intensity of stressor.
|
Baseline, 1 X between weeks 3-7, Week 8
|
|
Holmes and Rahe Social Readjustment Rating Scale (SRRS
Časové okno: Baseline, 1 X between weeks 3-7, Week 8
|
Stressful life events will be rated using the SRRS, which asks subjects to check if they have experienced any of a series of life events.
We will use a modification of the scale used in previous MS research that eliminates several items specifically associated with MS disease activity (e.g., "major illness or injury", "sexual difficulties", "pregnancy").
The SRRS differentiates three types of stress: positive ("outstanding personal achievement"), major negative stress (death of family member), conflict and disruption in routine (e.g., family or job conflict, life changes).
|
Baseline, 1 X between weeks 3-7, Week 8
|
|
Chicago Multiscale Depression Inventory (CMDI)
Časové okno: Baseline, 1 X betweeen Weeks 3-7, Week 8
|
CMDI is a self-report questionnaire designed specifically for use in MS and other medical patient groups.
It has vegetative, mood, and evaluative scales consisting of 14 items each.
The use of the CMDI makes it possible to separate out neurovegetative symptoms of depression which are a potential confound in medical populations such as MS
|
Baseline, 1 X betweeen Weeks 3-7, Week 8
|
|
State Trait Anxiety Inventory (STAI)
Časové okno: Baseline, 1 X betweeen Weeks 3-7, Week 8
|
The STAI is a widely used measure of state and trait anxiety.
We will focus on the measurement of state related anxiety in this study.
|
Baseline, 1 X betweeen Weeks 3-7, Week 8
|
|
Positive and Negative Affect Scale (PANAS)
Časové okno: Baseline, 1 X between Weeks 3 - 7, Week 8
|
; Watson, Clark & Tellegen, 1989): State related positive and negative affect will be assessed by the well validated PANAS scales.
|
Baseline, 1 X between Weeks 3 - 7, Week 8
|
|
Fatigue Severity Scale (FSS)
Časové okno: Baseline, 1 X between Weeks 3 - 7, Week 8
|
The fatigue severity scale is a reliable and valid commonly used measure of the frequent symptom of fatigue in MS.
|
Baseline, 1 X between Weeks 3 - 7, Week 8
|
|
MACFIMS neuropsychological battery
Časové okno: Baseline and Week 8
|
At baseline and study end, an abbreviated version of the MACFIMS will be administered.
This is a standard neurocognitive battery used with studies of MS subjects and includes the SDMT, PASAT, SRT, BVMT, and 9-hole peg test.
|
Baseline and Week 8
|
|
Expanded Disability Status Scale (EDSS)
Časové okno: Baseline and Week 8
|
Expanded Disability Status Scale is the oldest and probably the most widely utilized assessment instruments in MS for determination of neurological impairment in MS.
It is the standard for characterization of MS patients and for outcomes of clinical trials.
It will be used to characterize patients' level of disability.
|
Baseline and Week 8
|
|
Physiologic Markers of Stress
Časové okno: Baseline and Week 8
|
DHEA, epinephrine, and norepinephrine.
|
Baseline and Week 8
|
|
Physiologic Maker of Stress
Časové okno: Baseline, 1 X between Week 3 - 7, Weeek 8
|
cortisol
|
Baseline, 1 X between Week 3 - 7, Weeek 8
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Lauren B Krupp, M.D., Stony Brook University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- Teva186557-1
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Mindfulness based stress reduction (MBSR)
-
Assistance Publique - Hôpitaux de ParisNábor
-
Fatima Jinnah Women UniversityDokončenoTělesné postiženíPákistán
-
Gazi UniversityDokončenoFibromyalgický syndromTurecko (Türkiye)
-
Aleksandra Eriksen IshamUniversity of AarhusDokončenoDeprese | Snížení stresu založeného na všímavostiSpojené království
-
University Hospital FreiburgDokončeno
-
Washington University School of MedicineDokončeno
-
University of California, San FranciscoDokončenoStres | Chirurgická operace | Syndrom vyhořeníSpojené státy
-
Tampere UniversityDokončeno
-
University of PennsylvaniaNational Center for Complementary and Integrative Health (NCCIH)DokončenoŽádná podmínka | Zaměření je na nervové účinky tréninku všímavosti na pozornostSpojené státy